Barriers to and motivations for physician referral of patients to cancer genetics clinics

Journal of Genetic Counseling

Volumn 21, Issue 2, 2012, Pages 305-325

  Prochniak, Carrie F ^a   Martin, Lisa J ^b   Miller, Erin M ^c   Knapke, Sara C ^c  

^a AURORA HEALTH CARE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Genetic counseling; Genetic testing; Hereditary colorectal cancer; Referral; Risk assessment

Indexed keywords

ARTICLE; CLINICAL PRACTICE; GENETIC COUNSELING; GENETICS; HUMAN; MOTIVATION; NEOPLASM; PATIENT REFERRAL; QUESTIONNAIRE;

GENETIC COUNSELING; HUMANS; MOTIVATION; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; REFERRAL AND CONSULTATION;

EID: 84863628608     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-011-9401-x     Document Type: Article

References (31)

1. American Cancer Society. (2008). Colorectal cancer facts & figures 2008-2010. Atlanta: American Cancer Society.
2. American Cancer Society Colorectal Cancer Advisory Group, U. S. Multi-society Task Force, & American College of Radiology Colon Cancer Committee. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians, 58, 130-160.
3. American Gastroenterological Association. (2001). American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology, 121, 195-197.
4. American Society for Gastrointestinal Endoscopy. (2006). ASGE guideline: Colorectal cancer screening and surveillance. Gastrointestinal Endoscopy, 63(4), 546-557.
5. American Society of Clinical Oncology. (2005). Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology guideline. Journal of Clinical Oncology, 23(33), 8512-8519.
6. Batra, S., Valdimarsdottir, H., McGovern, M., Itzkowitz, S., & Brown, K. (2002). Awareness of genetic testing for cancer predisposition among specialists in gastroenterology. American Journal of Gastroenterology, 97(3), 729-733. (Pubitemid 34245905)
7. Bellcross, C., Kotor, K., Goddard, K. A. B., Coates, R. J., Reyes, M., & Khoury, M. J. (2011). Awareness and utilization of BRCA1/2 testing among U. S. primary care physicians. American Journal of Preventive Medicine, 40(1), 61-66.
8. Bleiker, E. M. A., Hahn, D. E. E., & Aaronson, N. K. (2003). Psychosocial issues in cancer genetics: Current status and future directions. Acta Oncologica, 42(4), 276-286. (Pubitemid 36851144)
9. Brandt, R., Ali, Z., Sabel, A., McHugh T., & Gilman, P. (2008). Cancer genetics evaluation: Barriers to and improvements for referral. Genetic Testing, 12(1), 9-12. (Pubitemid 351457780)
10. Brierley, K. L., Campfield, D., Ducane, W., Dohany, L., Donenberg, T., Shannon, K., et al. (2010). Errors in delivery of cancer genetics services: Implications for practice. Connecticut Medicine, 74(7), 413-423.
11. Collins, V., Halliday, J., Warren, R., & Williamson, R. (2000). Assessment of education and counselling offered by a familial colorectal cancer clinic. Clinical Genetics, 57(1), 48-55. (Pubitemid 30105560)
12. Ellis, C. N. (2008). Inherited colorectal cancer syndromes. retrieved April 18 2011, from American Society of Colon & Rectal Surgeons Web Site: http://www.fascrs.org/physicians/education/core-subjects/2008/ inherited-colorectal-cancer-syndromes
13. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. (2009). Recommendations from the EGAPP working group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortiality from Lynch syndrome in relatives. Genetics in Medicine, 11(1), 35-41.
14. Freedman, A. N., Wideroff, L., Olson, L., Davis, W., Klabunde, C., Srinath, K. P., et al. (2003). US physicians' attitudes toward genetic testing for cancer susceptibility. American Journal of Medical Genetics, 120 A, 63-71. (Pubitemid 37063834)
15. Grover, S., Stoffel, E. M., Bussone, L., Tschoegl, E., & Syngal, S. (2004). Physician assessment of family cancer history and referral for genetic evalution in colorectal cancer patients. Clinical Gastroenterology and Hepatology, 2, 813-819. (Pubitemid 39200720)
16. Hendricks, Y. M. C., de Jong, A. E., Morreau, H., Tops, C., Vasen, H. F. A., Wijnen, J. T., et al. (2006). Diagnostic approach and management of Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A guide for clinicians. CA: A Cancer Journal for Clinicians, 56(4), 213-225. (Pubitemid 44175050)
17. Huizenga, C. R., Lowstuter, K., Banks, K. C., Lagos, V. I., Vandergon, V. O., & Weitzel, J. N. (2010). Evolving perspectives on genetic discrimination in health insurance among health care providers. Familial Cancer, 9, 253-260.
18. Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomäki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118, 829-834. (Pubitemid 30243745)
19. Jenab-Wolcott, J., Tan, K., Heitjan, D. F., Giantonio, B. J., Garin, M., Powers, J., et al. (2011). Evaluation of physician knowledge and referral practices for colorectal cancer (CRC) genetic risk assessment: The experience at the Hospital of University of Pennsylvania (HUP) [Abstract]. Journal of Clinical Oncology, 29 (suppl 4; abstr 379)
20. Koil, C. E., Everett, J. N., Hoechstetter, L., Ricer, R. E., & Huelsman, K. M. (2003). Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genetics in Medicine, 5(5), 364-369. (Pubitemid 37264985)
21. Lowstuter, K. J., Sand, S., Blazer, K. R., MacDonald, D. J., Banks, K. C., Lee, C. A., et al. (2008). Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genetics in Medicine, 10(9), 691-698.
22. McCann, S., MacAuley, D., Barnett, Y., Bunting, B., Bradley, A., Jeffers, L., et al. (2007). Cancer genetics: Consultants' perceptions of their roles, confidence and satisfaction with knowledge. Journal of Evaluation in Clinical Practice, 13, 276-286. (Pubitemid 46449805)
23. Mukherjee, A., McGarrity, T. J., Ruggerio, F., Koltun, W., McKenna, K., Portiz, L., et al. (2010). The revised Bethesda guidelines: Extent of utilization in a university hospital medical center with a cancer genetics program. Hereditary Cancer in Clinical Practice, 8 (9).
24. National Comprehensive Cancer Network (NCCN). (2011). NCCN clinical practice guidelines in onocology: Genetic/familial highrisk assessment: Breast and ovarian
25. National Society of Genetic Counselors (NSGC). (2011). JEMF award recipients. Retrieved April 19, 2011, from http://www.nsgc.org/MemberCenter/ GrantsAwards/JEMFAwardRecipients/tabid/256/Default.aspx
26. Peters, J. A., & Biesecker, B. (1997). Genetic counseling and hereditary cancer. Cancer, 80(3), 577-586.
27. Singh, H., Schiesser, R., Anand, G., Richardson, P. A., & El-Serag, H. B. (2010). Underdiagnosis of Lynch syndrome involves more than family history criteria. Clinical Gastroenterology and Hepatology, 8, 523-529.
28. Terdiman, J. P. (2005). Colorectal cancer at a young age. Gastroenterology, 128, 1067-1076. (Pubitemid 40523556)
29. U. S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Annals of Internal Medicine, 143(5), 335-361.
30. Wideroff, L., Freedman, A. N., Olson, L., Klabunde, C., Davis, W., Srinath, K. P., et al. (2003). Physician use of genetic testing for cancer susceptibility: Results of a national survey. Cancer Epidemiology, Biomarkers & Prevention, 12, 295-303. (Pubitemid 36427989)
31. Wong, C., Gibbs, P., Johns, J., Jones, I., Faragher, I., Lynch, E., et al. (2008). Value of database linkage: Are patients at risk of familial colorectal cancer being referred for genetic counseling and testing? Internal Medicine Journal, 38, 328-333. (Pubitemid 351519480)